论文部分内容阅读
We developed two complement-fixing MoAbsHIM<sub>1</sub> and HIM<sub>4</sub> (murine)that were specifically reac-tive with chronic myelogenous leukemia (CML) cells.They were capable of fixing human or rabbit com-plement and suitable